Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P A Kelly

Showing results (321-330 of 417) with videos related to

Pageof 42
Sort By:
Endocrinology|August 5, 1999
The human growth hormone antagonist B2036 does not interact with the prolactin receptorV Goffin, S Bernichtein, O Carrière, et al.
Journal of Interventional Cardiac Electrophysiology : an International Journal of Arrhythmias and Pacing|May 9, 2001
Incidence and management of prolonged charge times in the Medtronic model 7219 implantable cardioverter defibrillatorD E Mann, S A Gleason, P A Kelly, et al.
Pacing and Clinical Electrophysiology : PACE|August 1, 1993
Palpitations occur frequently following radiofrequency catheter ablation for supraventricular tachycardia, but do not predict pathway recurrenceD E Mann, P A Kelly, S W Adler, et al.
FEBS Letters|November 8, 1982
Induction of beta-casein mRNA accumulation by the putative prolactin second messenger added to the culture medium of cultured mammary epithelial cellsJ L Servely, B Teyssot, L M Houdebine, et al.
Pacing and Clinical Electrophysiology : PACE|December 1, 1994
Implantation of an automatic defibrillator using a new nonthoracotomy approachP A Kelly, D E Mann, A H Harken, et al.
Annales D'Endocrinologie|January 1, 1995
[Growth hormone receptor. Structure and signal transduction]M C Postel-Vinay, J Finidori, A Sotiropoulos, et al.
Breast Cancer Research and Treatment|January 1, 1981
Total prolactin binding sites in human breast cancer biopsiesJ P Peyrat, D Dewailly, J Djiane, et al.
FEBS Letters|February 14, 1998
Homodimerization of IL-2 receptor beta chain is necessary and sufficient to activate Jak2 and downstream signaling pathwaysF Ferrag, A Pezet, A Chiarenza, et al.
Journal of Cardiovascular Electrophysiology|May 1, 1995
Tachycardia-induced cardiomyopathy in a cardiac transplant recipient: treatment with radiofrequency catheter ablationP Ott, P A Kelly, D E Mann, et al.
The EMBO Journal|January 2, 1996
PTP1D is a positive regulator of the prolactin signal leading to beta-casein promoter activationS Ali, Z Chen, J J Lebrun, et al.
Pageof 42

Showing results (321-330 of 417) with videos related to

Sort By:
Pageof 42
Endocrinology|August 5, 1999
The human growth hormone antagonist B2036 does not interact with the prolactin receptorV Goffin, S Bernichtein, O Carrière, et al.
Journal of Interventional Cardiac Electrophysiology : an International Journal of Arrhythmias and Pacing|May 9, 2001
Incidence and management of prolonged charge times in the Medtronic model 7219 implantable cardioverter defibrillatorD E Mann, S A Gleason, P A Kelly, et al.
Pacing and Clinical Electrophysiology : PACE|August 1, 1993
Palpitations occur frequently following radiofrequency catheter ablation for supraventricular tachycardia, but do not predict pathway recurrenceD E Mann, P A Kelly, S W Adler, et al.
FEBS Letters|November 8, 1982
Induction of beta-casein mRNA accumulation by the putative prolactin second messenger added to the culture medium of cultured mammary epithelial cellsJ L Servely, B Teyssot, L M Houdebine, et al.
Pacing and Clinical Electrophysiology : PACE|December 1, 1994
Implantation of an automatic defibrillator using a new nonthoracotomy approachP A Kelly, D E Mann, A H Harken, et al.
Annales D'Endocrinologie|January 1, 1995
[Growth hormone receptor. Structure and signal transduction]M C Postel-Vinay, J Finidori, A Sotiropoulos, et al.
Breast Cancer Research and Treatment|January 1, 1981
Total prolactin binding sites in human breast cancer biopsiesJ P Peyrat, D Dewailly, J Djiane, et al.
FEBS Letters|February 14, 1998
Homodimerization of IL-2 receptor beta chain is necessary and sufficient to activate Jak2 and downstream signaling pathwaysF Ferrag, A Pezet, A Chiarenza, et al.
Journal of Cardiovascular Electrophysiology|May 1, 1995
Tachycardia-induced cardiomyopathy in a cardiac transplant recipient: treatment with radiofrequency catheter ablationP Ott, P A Kelly, D E Mann, et al.
The EMBO Journal|January 2, 1996
PTP1D is a positive regulator of the prolactin signal leading to beta-casein promoter activationS Ali, Z Chen, J J Lebrun, et al.
Pageof 42